Home › Funds › STOLZ & ASSOCIATES, PS › CPRA

STOLZ & ASSOCIATES, PS position in CPRA

CALAMOS ETF TR

STOLZ & ASSOCIATES, PS reported holding 37,060 shares of CPRA (CALAMOS ETF TR) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.75% of its reported portfolio and ranking #14 among its reported holdings. STOLZ & ASSOCIATES, PS has disclosed CPRA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)37.06K sh
Reported value held$1.03M
Portfolio Weight0.75%
First reportedQ1 2026
Last changeHold
Updated2026-11-05

Last updated: 2026-11-05 · Source: SEC EDGAR Form 13F-HR

How STOLZ & ASSOCIATES, PS's CPRA position evolved

STOLZ & ASSOCIATES, PS first disclosed a stake in CPRA in Q1 2026 at 37,060 shares (US$1.0M). The position peaked in Q3 2026 at 37,060 shares, worth US$1.0M. Across 3 filings, STOLZ & ASSOCIATES, PS held the position steady without any share-count change. The most recent filing (Q3 2026) shows 37,060 shares valued at US$1.0M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 37.06K $1.01M New
Q2 2026 37.06K $1.03M Hold
Q3 2026 37.06K $1.03M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CPRA and 13F data

CPRA (CALAMOS ETF TR) is a company whose sector is not yet classified in our data. 7 other funds we track also report a position in CPRA. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CPRA

No other tracked fund reports a position in CPRA.

All CPRA fund holders →

FAQ

How long has STOLZ & ASSOCIATES, PS held CPRA?

STOLZ & ASSOCIATES, PS has disclosed CPRA holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is STOLZ & ASSOCIATES, PS's current position in CPRA?

As of Q3 2026, STOLZ & ASSOCIATES, PS holds 37.06K shares of CPRA (CALAMOS ETF TR), valued at $1.03M, representing 0.75% of its reported portfolio and ranking #14.

Has STOLZ & ASSOCIATES, PS been buying or selling CPRA?

In the latest 13F filing (Q3 2026), STOLZ & ASSOCIATES, PS held unchanged its position in CPRA. The position peaked in Q3 2026 at 37.06K shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.